Search Kisunla™ (type in keywords)
Search Medical Information
If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX (1-800-545-5979)
Kisunla ™ (donanemab-azbt) injection, for intravenous infusion
350 mg/20 mL (17.5 mg/mL)
This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.
Are sales representatives available for Kisunla™ (donanemab-azbt)?
To request a sales representative visit for Kisunla, please complete and submit the electronic request form.
Information
To request a sales representative visit, please complete and submit the Sales Representative Request Form.
Date of Last Review: February 23, 2024
Are you satisfied with this content?